You just read:

Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia

News provided by

Inovio Pharmaceuticals, Inc.

Aug 19, 2019, 09:00 ET